BG Medicine said this week that revenues for the second quarter increased 181 percent year over year, rising to $622,000 from $221,000 a year ago and beating the average Wall Street estimate of $520,000.
BG Medicine said last week that it filed a 510(k) submission with the US Food & Drug Administration for an automated version of its BGM Galectin-3 heart failure test to be run on Abbott Laboratories' Architect platform.
At a meeting hosted by the Centers for Medicare & Medicaid Services this week to determine payment levels for genetic tests placed in the clinical laboratory fee schedule, lab industry professionals remained at loggerheads with pathologists who maintained that the physician f
Matthias Mann, director of the Max Planck Institute of Biochemistry, has been awarded the 2012 Korber European Science Prize for his work in proteomics.
The prize, which will be present on Sept. 7, comes with a €750,000 ($940,000) award.
NEW YORK (GenomeWeb News) – Mark Boguski, a faculty member at the Harvard Medical School and Beth Israel Deaconess Medical Center, has co-founded a new consulting company called Genome Health Solutions.